follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Protalex completes $2.8M private placement

By

Back to Top Comments Email Print

Latest News

advertisement

Florham Park-based biopharmaceutical company Protalex announced Thursday it has completed a private placement financing in the amount of $2.82 million.

According to the announcement, the placement accredited investors in the form of 471,334 shares of common stock at $6 per share. Proceeds of the financing will be used for working capital purposes, principally to fund ongoing clinical trials and studies and related activities.


Like NJBIZ on Facebook: facebook.com/NJBIZ

Stay informed with free NJBIZ email newsletters >

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top